Skip to main content
. 2011 Jan 27;32(4):516–521. doi: 10.1093/carcin/bgr005

Table I.

Genotyping of the three rare variants

Variant Amino acid substitution Allele frequency amongst controls Genotype Controls (%) Cases (%) OR (95% CI)
c.2251-37 rs2470353 Triallelic: C>G SNP, C>A rare variant Intron 11 0 CC 201 (27.2) 183 (25.4) 1
CG 358 (48.4) 347 (48.1) 1.1 (0.8–1.4)
GG 181 (24.5) 190 (26.3) 1.2 (0.9–1.5)
CA 0 (0) 2 (0.28) ND
AA 0 (0) 0 (0) ND
c.1177C>T rs121965090 Arg393Trp 0.002 CC 790 (99.6) 750 (99.1) 1.0
CT 3 (0.4) 7 (0.9) 2.5 (0.6–9.5)
TT 0 (0) 0 (0) ND
c.905T>C rs121965091 Phe302Ser 0.0006 TT 787 (99.9) 757 (99.7) 1.0
TC 1 (0.1) 2 (0.3) 2.1 (0.2–23.0)
CC 0 (0) 0 (0) ND
c.*156G>A rs121965092 3′ UTR 0 GG 785 (100) 759 (99.9) 1.0
GA 0 (0) 1 (0.1) ND
AA 0 (0) 0 (0) ND
c.2251-37C>A, c.1177C>T c.905T>C and c.*156G>A combined No rare allele 771 (99.5) 735 (98.4) 1.0
≥1 rare allele 4 (0.5) 12 (1.6) 3.1 (1.0–9.8)a
a

Statistically significant with P-value < 0.05.